Concepedia

Publication | Open Access

A MET Targeting Antibody–Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer

33

Citations

28

References

2021

Year

Abstract

Together, these results suggest the promise of agents such as TR1801-ADC as a novel approach to the treatment of pancreatic cancer.

References

YearCitations

Page 1